Kaken Pharmaceutical Co., Ltd. (4521)
Market Closed
10 Aug, 06:00
JPX JPX Primary 
OTC PINK ¥
4,000. 00
+100
+2.5641%
¥
146.55B Market Cap
- P/E Ratio
190% Div Yield
284,100 Volume
- Eps
¥ 3,900
Previous Close Want to track 4521 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kaken Pharmaceutical Co., Ltd. (4521) Statistics
Valuation metrics
Market Cap 146.55B
Enterprise value 106.82B
Trailing P/E (ttm) 68.94
Forward P/E 43.1
PEG ratio -0.41
Price/Sales (ttm) 1.92
Price/Book (mrq) 1
Enterprise Value/Revenue 1.39
Enterprise Value/EBITDA 18.79
Overview
Shares outstanding 37.87M
Float 32.45M
Shares short -
% Held by insiders 0.17%
% Held by institutions 0.21%
Average volume (10 days) 182.07K
Average volume (90 days) 116.84K
Price summary
52-Week low 3,540
52-Week high 4,445
Beta 0.13
50-Day moving average 3,843
200-Day moving average 4,051.47
Dividends and splits
Forward annual dividend rate 190
Forward annual dividend yield 0.0461%
Trailing annual dividend rate 190
Trailing annual dividend yield 0.0487%
5-Year annual dividend yield 3.92%
Payout ratio 11.85
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 1:2
Last split Date 28 Sep 2015
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.03%
Operating margin -0.01%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.01%
Income Statement
Revenue (ttm) 76.87B
Revenue per share (ttm) 2,029.06
Quarterly revenue growth (yoy) 0.07%
Gross profit (ttm) 39.99B
EBITDA 23.89B
Net income to common (ttm) 2.14B
Diluted EPS (ttm) 56.59
Quarterly earnings growth (yoy) -0.92%
Balance Sheet
Total cash (mrq) 50.7B
Total cash per share (mrq) 1,338.39
Total debt (mrq) 3.85B
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 4.52%
Book value per share (mrq) 3,896.58
Cash Flow
Cash flow statement -11.08B
Levered free cash flow (LFCF) -14.29B
